company background image
BMY logo

Bristol-Myers Squibb NYSE:BMY Stock Report

Last Price

US$59.94

Market Cap

US$120.1b

7D

2.0%

1Y

19.9%

Updated

02 Dec, 2024

Data

Company Financials +

Bristol-Myers Squibb Company

NYSE:BMY Stock Report

Market Cap: US$120.1b

BMY Stock Overview

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. More details

BMY fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends4/6

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

Bristol-Myers Squibb Company Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bristol-Myers Squibb
Historical stock prices
Current Share PriceUS$59.94
52 Week HighUS$61.08
52 Week LowUS$39.35
Beta0.44
11 Month Change10.35%
3 Month Change18.65%
1 Year Change19.93%
33 Year Change5.47%
5 Year Change-2.19%
Change since IPO2,705.24%

Recent News & Updates

Revenues Not Telling The Story For Bristol-Myers Squibb Company (NYSE:BMY)

Nov 27
Revenues Not Telling The Story For Bristol-Myers Squibb Company (NYSE:BMY)

5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

Nov 25

Recent updates

Revenues Not Telling The Story For Bristol-Myers Squibb Company (NYSE:BMY)

Nov 27
Revenues Not Telling The Story For Bristol-Myers Squibb Company (NYSE:BMY)

5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

Nov 25

Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren

Oct 28

Bristol-Myers Squibb: A High-Yield Bargain With Growth On The Horizon

Oct 06

Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)

Sep 27

Bristol-Myers Still A Value Play Despite Appreciating 26.56% From 2024 Lows

Sep 06

Bristol-Myers Squibb Company's (NYSE:BMY) Share Price Is Matching Sentiment Around Its Revenues

Aug 15
Bristol-Myers Squibb Company's (NYSE:BMY) Share Price Is Matching Sentiment Around Its Revenues

Bristol-Myers Squibb: A Potential Comeback In Healthcare

Aug 06

Bristol-Myers Squibb: Q2 Earnings Look Like An Inflection Point

Jul 27

Bristol Myers Squibb: The More It Drops, The More I Buy

Jul 16

Is Bristol-Myers Squibb (NYSE:BMY) A Risky Investment?

Jun 13
Is Bristol-Myers Squibb (NYSE:BMY) A Risky Investment?

Bristol Myers: Quality Fundamentals Suppressed By Interest Rates

Jun 09

Bristol-Myers Squibb: Looking Beyond The One-Time Quarterly Loss

Jun 03

Bristol-Myers Squibb: 5.5% Yielder Has Been Crushed In What Could Be A Generational Buying Opportunity

May 23

Bristol-Myers Squibb: A Lost Decade?

May 03

Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S

Apr 29
Lacklustre Performance Is Driving Bristol-Myers Squibb Company's (NYSE:BMY) Low P/S

Is Bristol Myers Squibb A Buy At These Bottom Levels?

Apr 22

Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)

Apr 12

Bristol-Myers Squibb Is A Speculative Buy On Price Action (Technical Analysis)

Apr 02

Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60

Mar 21
Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60

Bristol-Myers Squibb Is Not A Buy For Me

Mar 19

Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield

Mar 07

Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60

Mar 07
Bristol-Myers Squibb (NYSE:BMY) Is Due To Pay A Dividend Of $0.60

Shareholder Returns

BMYUS PharmaceuticalsUS Market
7D2.0%1.9%0.7%
1Y19.9%12.1%32.2%

Return vs Industry: BMY exceeded the US Pharmaceuticals industry which returned 12.1% over the past year.

Return vs Market: BMY underperformed the US Market which returned 32.2% over the past year.

Price Volatility

Is BMY's price volatile compared to industry and market?
BMY volatility
BMY Average Weekly Movement4.4%
Pharmaceuticals Industry Average Movement10.0%
Market Average Movement6.3%
10% most volatile stocks in US Market16.4%
10% least volatile stocks in US Market3.1%

Stable Share Price: BMY has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: BMY's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
188734,100Chris Boernerwww.bms.com

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation, and for the treatment of DVT/PE; Opdivo for various anti-cancer indications, including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia.

Bristol-Myers Squibb Company Fundamentals Summary

How do Bristol-Myers Squibb's earnings and revenue compare to its market cap?
BMY fundamental statistics
Market capUS$120.11b
Earnings (TTM)-US$7.26b
Revenue (TTM)US$47.44b

2.6x

P/S Ratio

-16.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BMY income statement (TTM)
RevenueUS$47.44b
Cost of RevenueUS$11.44b
Gross ProfitUS$35.99b
Other ExpensesUS$43.25b
Earnings-US$7.26b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 06, 2025

Earnings per share (EPS)-3.58
Gross Margin75.87%
Net Profit Margin-15.30%
Debt/Equity Ratio289.5%

How did BMY perform over the long term?

See historical performance and comparison

Dividends

4.0%

Current Dividend Yield

-67%

Payout Ratio